Samenvatting
Studies aimed at supporting different treatment approaches for pantothenate kinase-associated neurodegeneration (PKAN) have revealed the complexity of coenzyme A (CoA) metabolism and the limits of our current knowledge about disease pathogenesis. Here we offer a foundation for critically evaluating the myriad approaches, argue for the importance of unbiased disease models, and highlight some of the outstanding questions that are central to our understanding and treating PKAN.
Originele taal-2 | English |
---|---|
Pagina's (van-tot) | 283-291 |
Aantal pagina's | 9 |
Tijdschrift | Molecular Genetics and Metabolism |
Volume | 137 |
Nummer van het tijdschrift | 3 |
DOI's | |
Status | Published - nov.-2022 |